Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
GC376 Potential treatment - pre-clinical evidence Experimental Antiviral Apr/28/2021 12 0
Camostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/22/2021 12 1
Aloxistatin Potential treatment - pre-clinical evidence Experimental Antiviral Mar/27/2021 2 0
Rapamycin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/25/2021 6 0
Temsirolimus Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/25/2021 3 0
Everolimus Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/25/2021 3 0
Nafamostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/20/2021 12 0
Nebivolol Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/18/2021 3 0
Boceprevir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/01/2021 13 0
Excel (.xslx) CSV (.csv)